Caoimhe Casey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Caoimhe Casey has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Sean F Dinneen
Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Galway, County Galway
3 shared publicationsTomás P Griffin
Alliance for Research and Innovation in Wounds (ARIW), College of Medicine, Nursing and Health Sciences, University of Galway, Galway, County Galway
3 shared publicationsClaire M Buckley
School of Public Health, University College Cork
2 shared publications- Claire M. Buckley
School of Public Health Cork County Cork University College Cork
2 shared publications - Matthew D. Griffin
Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, College of Medicine, Nursing and Health Sciences, University of Galway, Ireland; Renal Services, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland
2 shared publications Patricia M Kearney
School of Public Health, University College Cork
2 shared publications
Latest Publications
- Open Access
- 6 June 2025
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 8, 64
Social deprivation and foot disease outcomes in people with Diabetes Mellitus and Chronic Kidney Disease: A Systematic Reviews and Meta-Analysis Protocol
Background Diabetes Mellitus (DM) and Chronic Kidney Disease (CKD) prevalence has increased and has raised multiple secondary concerns. Both conditions independently, and unanimously, contribute to the elevated morbidity and mortality rates in people with DM, increasing demands on healthcare systems. Patients presenting with CKD have greater levels of foot disease outcomes, including foot ulceration, amputation and subsequent mortality. These individuals are impacted with significant and complex clinical concerns with severe complications. However, the intricate interplay between CKD and diabetes-related foot disease outcomes in the context of social deprivation has not been investigated from an evidence synthesis perspective Aim We aim to identify if there is an association between social deprivation and foot disease outcomes in individuals with DM and CKD. Methods and analysis In accordance with the Preferred Reporting Items for Systematic Review and Meta-analyses, this protocol is reported in line with PRISMA-P guidelines. Three databases will be utilised to identify eligible studies reporting foot disease outcomes in people with DM and CKD. A MEDLINE search strategy was adapted to improve sensitivity and specificity for social deprivation-focused studies. Endnote and Covidence will manage records, with blinded screening and independent data extraction by three reviewers, with discrepancies resolved through discussion with a fourth reviewer. We will assess the risk of bias at both the study and outcome levels using established tools: the MOOSE Guidelines for meta-analysis in Observational studies and the JBI Manual for Evidence synthesis. Pooled odds ratios and standardised mean differences with 95% confidence intervals for nominal and continuous data will be calculated employing either a fixed-effects or random-effects model based on heterogeneity (I² < 50% for fixed-effects and I² > 50% for random-effects models). Sensitivity analyses will address missing data and heterogeneity, and GRADE will evaluate the quality of the evidence. PROSPERO registration number: CRD42024542991 Registration The systematic review protocol was published with the International Prospective Register of Systematic Review on the 12th of August, 2024 (registration number: CRD42024542991).
- 6 June 2025
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 8, 64
Open AccessSocial deprivation and foot disease outcomes in people with Diabetes Mellitus and Chronic Kidney Disease: A Systematic Reviews and Meta-Analysis Protocol
Background Diabetes Mellitus (DM) and Chronic Kidney Disease (CKD) prevalence has increased and has raised multiple secondary concerns. Both conditions independently, and unanimously, contribute to the elevated morbidity and mortality rates in people with DM, increasing demands on healthcare systems. Patients presenting with CKD have greater levels of foot disease outcomes, including foot ulceration, amputation and subsequent mortality. These individuals are impacted with significant and complex clinical concerns with severe complications. However, the intricate interplay between CKD and diabetes-related foot disease outcomes in the context of social deprivation has not been investigated from an evidence synthesis perspective Aim We aim to identify if there is an association between social deprivation and foot disease outcomes in individuals with DM and CKD. Methods and analysis In accordance with the Preferred Reporting Items for Systematic Review and Meta-analyses, this protocol is reported in line with PRISMA-P guidelines. Three databases will be utilised to identify eligible studies reporting foot disease outcomes in people with DM and CKD. A MEDLINE search strategy was adapted to improve sensitivity and specificity for social deprivation-focused studies. Endnote and Covidence will manage records, with blinded screening and independent data extraction by three reviewers, with discrepancies resolved through discussion with a fourth reviewer. We will assess the risk of bias at both the study and outcome levels using established tools: the MOOSE Guidelines for meta-analysis in Observational studies and the JBI Manual for Evidence synthesis. Pooled odds ratios and standardised mean differences with 95% confidence intervals for nominal and continuous data will be calculated employing either a fixed-effects or random-effects model based on heterogeneity (I² < 50% for fixed-effects and I² > 50% for random-effects models). Sensitivity analyses will address missing data and heterogeneity, and GRADE will evaluate the quality of the evidence. PROSPERO registration number: CRD42024542991 Registration The systematic review protocol was published with the International Prospective Register of Systematic Review on the 12th of August, 2024 (registration number: CRD42024542991).
- Open Access
- 8 August 2024
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 7, 53
The impact of social deprivation on development and progression of diabetic kidney disease
Introduction Diabetes is one of the leading causes of chronic kidney disease. Social deprivation is recognised as a risk factor for complications of diabetes, including diabetic kidney disease. The effect of deprivation on rate of decline in renal function has not been explored in the Irish Health System to date. The objective of this study is to explore the association between social deprivation and the development/progression of diabetic kidney disease in a cohort of adults living with diabetes in Ireland. Methods This is a retrospective cohort study using an existing dataset of people living with diabetes who attended the diabetes centre at University Hospital Galway from 2012 to 2016. The variables included in this dataset include demographic variables, type and duration of diabetes, clinical variables such as medication use, blood pressure and BMI and laboratory data including creatinine, urine albumin to creatinine to ratio, haemoglobin A1c and lipids. This dataset will be updated with laboratory data until January 2023. Individual’s addresses will be used to calculate deprivation indices using the Pobal Haase Pratschke (HP) deprivation index. Rate of renal function decline will be calculated using linear mixed-effect models. The relationship between deprivation and renal function will be assessed using linear regression (absolute and relative rate of renal function decline based on eGFR) and logistic regression models (rapid vs. non-rapid decline).
- 8 August 2024
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 7, 53
Open AccessThe impact of social deprivation on development and progression of diabetic kidney disease
Introduction Diabetes is one of the leading causes of chronic kidney disease. Social deprivation is recognised as a risk factor for complications of diabetes, including diabetic kidney disease. The effect of deprivation on rate of decline in renal function has not been explored in the Irish Health System to date. The objective of this study is to explore the association between social deprivation and the development/progression of diabetic kidney disease in a cohort of adults living with diabetes in Ireland. Methods This is a retrospective cohort study using an existing dataset of people living with diabetes who attended the diabetes centre at University Hospital Galway from 2012 to 2016. The variables included in this dataset include demographic variables, type and duration of diabetes, clinical variables such as medication use, blood pressure and BMI and laboratory data including creatinine, urine albumin to creatinine to ratio, haemoglobin A1c and lipids. This dataset will be updated with laboratory data until January 2023. Individual’s addresses will be used to calculate deprivation indices using the Pobal Haase Pratschke (HP) deprivation index. Rate of renal function decline will be calculated using linear mixed-effect models. The relationship between deprivation and renal function will be assessed using linear regression (absolute and relative rate of renal function decline based on eGFR) and logistic regression models (rapid vs. non-rapid decline).
- Open Access
Study Protocol- The impact of social deprivation on development and progression of diabetic kidney disease
Introduction Diabetes is one of the leading causes of chronic kidney disease. Social deprivation is recognised as a risk factor for complications of diabetes, including diabetic kidney disease. The effect of deprivation on rate of decline in renal function has not been explored in the Irish Health System to date. The objective of this study is to explore the association between social deprivation and the development/progression of diabetic kidney disease in a cohort of adults living with diabetes in Ireland. Methods and analysis This is a retrospective cohort study using an existing dataset of people living with diabetes who attended the diabetes centre at University Hospital Galway from 2012 to 2016. The variables included in this dataset include demographic variables, type and duration of diabetes, clinical variables such as medication use, blood pressure and BMI and laboratory data including creatinine, urine albumin to creatinine to ratio, haemoglobin A1c and lipids. This dataset will be updated with laboratory data until January 2023. Individual’s addresses will be used to calculate deprivation indices using the Pobal Haase Pratschke (HP) deprivation index. Rate of renal function decline will be calculated using linear mixed-effect models. The relationship between deprivation and renal function will be assessed using linear regression (absolute and relative rate of renal function decline based on eGFR) and logistic regression models (rapid vs. non-rapid decline). Ethics and dissemination Ethical approval has been granted by the clinical research ethics committee of Galway University Hospitals-Ref C.A. 2956. Results will be presented at conferences and published in peer review journals.
Open AccessStudy Protocol- The impact of social deprivation on development and progression of diabetic kidney disease
Introduction Diabetes is one of the leading causes of chronic kidney disease. Social deprivation is recognised as a risk factor for complications of diabetes, including diabetic kidney disease. The effect of deprivation on rate of decline in renal function has not been explored in the Irish Health System to date. The objective of this study is to explore the association between social deprivation and the development/progression of diabetic kidney disease in a cohort of adults living with diabetes in Ireland. Methods and analysis This is a retrospective cohort study using an existing dataset of people living with diabetes who attended the diabetes centre at University Hospital Galway from 2012 to 2016. The variables included in this dataset include demographic variables, type and duration of diabetes, clinical variables such as medication use, blood pressure and BMI and laboratory data including creatinine, urine albumin to creatinine to ratio, haemoglobin A1c and lipids. This dataset will be updated with laboratory data until January 2023. Individual’s addresses will be used to calculate deprivation indices using the Pobal Haase Pratschke (HP) deprivation index. Rate of renal function decline will be calculated using linear mixed-effect models. The relationship between deprivation and renal function will be assessed using linear regression (absolute and relative rate of renal function decline based on eGFR) and logistic regression models (rapid vs. non-rapid decline). Ethics and dissemination Ethical approval has been granted by the clinical research ethics committee of Galway University Hospitals-Ref C.A. 2956. Results will be presented at conferences and published in peer review journals.
- Open Access
- 27 January 2024
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 15 (5) , 541-556
Social deprivation and diabetic kidney disease: A European view
There is a large body of literature demonstrating a social gradient in health and increasing evidence of an association between social deprivation and diabetes complications. Diabetic kidney disease (DKD) increases mortality in people with diabetes. Socioeconomic deprivation is increasingly recognized as a modifier of risk factors for kidney disease but also an independent risk factor itself for kidney disease. This may not be truly appreciated by clinicians and warrants further attention and exploration. In this review we explore the literature to date from Europe on the relationship between social deprivation and DKD. The majority of the studies showed at least an association with microalbuminuria, an early marker of DKD, while many showed an association with overt nephropathy. This was seen across many countries in Europe using a variety of different measures of deprivation. We reviewed and considered the mechanisms by which deprivation may lead to DKD. Health related behaviors such as smoking and suboptimal control of risk factors such as hypertension, hyperglycemia and elevated body mass index (BMI) accounts for some but not all of the association. Poorer access to healthcare, health literacy, and stress are also discussed as potential mediators of the association. Addressing deprivation is difficult but starting points include targeted interventions for people living in deprived circumstances, equitable roll out of diabetes technology, and flexible outpatient clinic arrangements including virtual and community‐based care.
- 27 January 2024
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 15 (5) , 541-556
Open AccessSocial deprivation and diabetic kidney disease: A European view
There is a large body of literature demonstrating a social gradient in health and increasing evidence of an association between social deprivation and diabetes complications. Diabetic kidney disease (DKD) increases mortality in people with diabetes. Socioeconomic deprivation is increasingly recognized as a modifier of risk factors for kidney disease but also an independent risk factor itself for kidney disease. This may not be truly appreciated by clinicians and warrants further attention and exploration. In this review we explore the literature to date from Europe on the relationship between social deprivation and DKD. The majority of the studies showed at least an association with microalbuminuria, an early marker of DKD, while many showed an association with overt nephropathy. This was seen across many countries in Europe using a variety of different measures of deprivation. We reviewed and considered the mechanisms by which deprivation may lead to DKD. Health related behaviors such as smoking and suboptimal control of risk factors such as hypertension, hyperglycemia and elevated body mass index (BMI) accounts for some but not all of the association. Poorer access to healthcare, health literacy, and stress are also discussed as potential mediators of the association. Addressing deprivation is difficult but starting points include targeted interventions for people living in deprived circumstances, equitable roll out of diabetes technology, and flexible outpatient clinic arrangements including virtual and community‐based care.
- Open Access
- 8 May 2023
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 1 (3) , luad050
Herpes Simplex Virus Diencephalitis Leading to Panhypopituitarism
Herpes simplex virus (HSV) is one of the most common causes of viral encephalitis. Hypothalamic-pituitary dysfunction has rarely been reported in HSV encephalitis, with few reports into the longer term outcomes for these patients. A 46-year-old male presented with a 10-day history of delirium, fever, and polydipsia. Initial computed tomography of the brain and cerebrospinal fluid cell counts were normal. Magnetic resonance imaging showed T2-hyperintensity affecting bilateral infundibuli, hypothalami, subthalamic nuclei, and optic radiations. Serial cerebrospinal fluid detected HSV1 DNA and we diagnosed him with HSV diencephalitis. He had marked biochemical abnormalities from the outset, with dramatic changes in serum sodium levels. He was ultimately diagnosed with permanent central diabetes insipidus and panhypopituitarism following evidence of central hypothyroidism, hypogonadotrophic hypogonadism, and a flat cortisol response to an insulin tolerance test. Neurocognitive recovery took several months, but subtle deficits in executive function and information processing remain. Hypothalamic hyperphagia developed as well as temperature dysregulation. He requires lifelong hormonal replacement and is undergoing regular endocrine follow up. This case highlights hypothalamic-pituitary dysfunction as a rare endocrine complication of HSV diencephalitis and illustrates the complexity of managing this in the long term.
- 8 May 2023
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 1 (3) , luad050
Open AccessHerpes Simplex Virus Diencephalitis Leading to Panhypopituitarism
Herpes simplex virus (HSV) is one of the most common causes of viral encephalitis. Hypothalamic-pituitary dysfunction has rarely been reported in HSV encephalitis, with few reports into the longer term outcomes for these patients. A 46-year-old male presented with a 10-day history of delirium, fever, and polydipsia. Initial computed tomography of the brain and cerebrospinal fluid cell counts were normal. Magnetic resonance imaging showed T2-hyperintensity affecting bilateral infundibuli, hypothalami, subthalamic nuclei, and optic radiations. Serial cerebrospinal fluid detected HSV1 DNA and we diagnosed him with HSV diencephalitis. He had marked biochemical abnormalities from the outset, with dramatic changes in serum sodium levels. He was ultimately diagnosed with permanent central diabetes insipidus and panhypopituitarism following evidence of central hypothyroidism, hypogonadotrophic hypogonadism, and a flat cortisol response to an insulin tolerance test. Neurocognitive recovery took several months, but subtle deficits in executive function and information processing remain. Hypothalamic hyperphagia developed as well as temperature dysregulation. He requires lifelong hormonal replacement and is undergoing regular endocrine follow up. This case highlights hypothalamic-pituitary dysfunction as a rare endocrine complication of HSV diencephalitis and illustrates the complexity of managing this in the long term.
- Open Access
- 17 August 2022
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2022 (1)
Subacute thyroiditis post viral vector vaccine for COVID-19
Summary Subacute thyroiditis is an inflammatory disorder of the thyroid gland that has previously been described following viral illnesses and occasionally post vaccination such as influenza vaccine. 2021 was a revolutionary year for the development of SARS-CoV-2 vaccinations with multiple different vaccines now available. There are increasing numbers of case reports of thyroiditis following these vaccinations. We report a case of a 50-year-old female who developed subacute thyroiditis 6 days post ChAdOx1 nCoV-19 vaccine (AZD1222 produced by AstraZeneca Vaxzevria). The initial thyrotoxic phase was followed by overt hypothyroidism. This resolved spontaneously within 5 months without levothyroxine replacement. We hope that our case will add to the growing literature of cases of thyroiditis occurring after multiple different types of SARS-CoV-2 vaccination and create awareness of this rare but treatable adverse effect. We also review the literature on the proposed mechanisms behind this adverse effect. Learning points Subacute thyroiditis is an inflammatory disorder of the thyroid gland that can occur after a viral illness or vaccination against certain infections. Subacute thyroiditis is a rare adverse effect that has been reported to occur after different types of SARS-CoV-2 vaccinations. Subacute thyroiditis post vaccination is relatively straightforward to manage, with some patients requiring non-steroidal anti-inflammatory drugs and beta-blockers, while more severe cases may require corticosteroid therapy. This adverse effect should not dissuade vaccination use at a population level. There are many postulated mechanisms for the development of subacute thyroiditis following vaccination including the presence of the ACE-2 receptor for SARS-CoV-2 on the thyroid gland, an inflammatory/immune response as is seen in COVID-19 infection itself and molecular mimicry between SARS-CoV-2 spike protein and healthy thyroid antigen. Abstract Summary Subacute thyroiditis is an inflammatory disorder of the thyroid gland that has previously been described following viral illnesses and occasionally post vaccination such as influenza vaccine. 2021 was a revolutionary year for the development of SARS-CoV-2 vaccinations with multiple different vaccines now available. There are increasing numbers of case reports of thyroiditis following these vaccinations. We report a case of a 50-year-old female who developed subacute thyroiditis 6 days post ChAdOx1 nCoV-19 vaccine (AZD1222 produced by AstraZeneca Vaxzevria). The initial thyrotoxic phase was followed by overt hypothyroidism. This resolved spontaneously within 5 months without levothyroxine replacement. We hope that our case will add to the growing literature of cases of thyroiditis occurring after multiple different types of SARS-CoV-2 vaccination and create awareness of this rare but treatable adverse effect. We also review the literature on the proposed mechanisms behind this adverse effect. Learning points Subacute thyroiditis is an inflammatory disorder of the thyroid gland that can occur after a viral illness or vaccination against certain infections. Subacute thyroiditis is a rare adverse effect that has been reported to occur after different types of SARS-CoV-2 vaccinations. Subacute thyroiditis post vaccination is relatively straightforward to manage, with some patients requiring non-steroidal anti-inflammatory drugs and beta-blockers, while more severe cases may require corticosteroid therapy. This adverse effect should not dissuade vaccination use at a population level. There are many postulated mechanisms for the development of subacute thyroiditis following vaccination including the presence of the ACE-2 receptor for SARS-CoV-2 on the thyroid gland, an inflammatory/immune response as is seen in COVID-19 infection itself and molecular mimicry between SARS-CoV-2 spike protein and healthy thyroid antigen.
- 17 August 2022
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2022 (1)
Open AccessSubacute thyroiditis post viral vector vaccine for COVID-19
Summary Subacute thyroiditis is an inflammatory disorder of the thyroid gland that has previously been described following viral illnesses and occasionally post vaccination such as influenza vaccine. 2021 was a revolutionary year for the development of SARS-CoV-2 vaccinations with multiple different vaccines now available. There are increasing numbers of case reports of thyroiditis following these vaccinations. We report a case of a 50-year-old female who developed subacute thyroiditis 6 days post ChAdOx1 nCoV-19 vaccine (AZD1222 produced by AstraZeneca Vaxzevria). The initial thyrotoxic phase was followed by overt hypothyroidism. This resolved spontaneously within 5 months without levothyroxine replacement. We hope that our case will add to the growing literature of cases of thyroiditis occurring after multiple different types of SARS-CoV-2 vaccination and create awareness of this rare but treatable adverse effect. We also review the literature on the proposed mechanisms behind this adverse effect. Learning points Subacute thyroiditis is an inflammatory disorder of the thyroid gland that can occur after a viral illness or vaccination against certain infections. Subacute thyroiditis is a rare adverse effect that has been reported to occur after different types of SARS-CoV-2 vaccinations. Subacute thyroiditis post vaccination is relatively straightforward to manage, with some patients requiring non-steroidal anti-inflammatory drugs and beta-blockers, while more severe cases may require corticosteroid therapy. This adverse effect should not dissuade vaccination use at a population level. There are many postulated mechanisms for the development of subacute thyroiditis following vaccination including the presence of the ACE-2 receptor for SARS-CoV-2 on the thyroid gland, an inflammatory/immune response as is seen in COVID-19 infection itself and molecular mimicry between SARS-CoV-2 spike protein and healthy thyroid antigen. Abstract Summary Subacute thyroiditis is an inflammatory disorder of the thyroid gland that has previously been described following viral illnesses and occasionally post vaccination such as influenza vaccine. 2021 was a revolutionary year for the development of SARS-CoV-2 vaccinations with multiple different vaccines now available. There are increasing numbers of case reports of thyroiditis following these vaccinations. We report a case of a 50-year-old female who developed subacute thyroiditis 6 days post ChAdOx1 nCoV-19 vaccine (AZD1222 produced by AstraZeneca Vaxzevria). The initial thyrotoxic phase was followed by overt hypothyroidism. This resolved spontaneously within 5 months without levothyroxine replacement. We hope that our case will add to the growing literature of cases of thyroiditis occurring after multiple different types of SARS-CoV-2 vaccination and create awareness of this rare but treatable adverse effect. We also review the literature on the proposed mechanisms behind this adverse effect. Learning points Subacute thyroiditis is an inflammatory disorder of the thyroid gland that can occur after a viral illness or vaccination against certain infections. Subacute thyroiditis is a rare adverse effect that has been reported to occur after different types of SARS-CoV-2 vaccinations. Subacute thyroiditis post vaccination is relatively straightforward to manage, with some patients requiring non-steroidal anti-inflammatory drugs and beta-blockers, while more severe cases may require corticosteroid therapy. This adverse effect should not dissuade vaccination use at a population level. There are many postulated mechanisms for the development of subacute thyroiditis following vaccination including the presence of the ACE-2 receptor for SARS-CoV-2 on the thyroid gland, an inflammatory/immune response as is seen in COVID-19 infection itself and molecular mimicry between SARS-CoV-2 spike protein and healthy thyroid antigen.
- Open Access
- 15 April 2013
- Published by Springer Nature in BMC Research Notes
- Vol. 6 (1) , 148
Concordance studies between hospital discharge data and medical records for the recording of lower extremity amputation and diabetes in the Republic of Ireland
Hospital discharge data have been used to study trends in Lower Extremity Amputation (LEA) rates in people with and without diabetes. The aim of this study was to assess the reliability of routine hospital discharge data in the Republic of Ireland (RoI) for this purpose by determining the level of agreement between hospital discharge data and medical records for both the occurrence of LEA and diagnosis of diabetes.
- 15 April 2013
- Published by Springer Nature in BMC Research Notes
- Vol. 6 (1) , 148
Open AccessConcordance studies between hospital discharge data and medical records for the recording of lower extremity amputation and diabetes in the Republic of Ireland
Hospital discharge data have been used to study trends in Lower Extremity Amputation (LEA) rates in people with and without diabetes. The aim of this study was to assess the reliability of routine hospital discharge data in the Republic of Ireland (RoI) for this purpose by determining the level of agreement between hospital discharge data and medical records for both the occurrence of LEA and diagnosis of diabetes.